SPRINT Peripheral Nerve Stimulation System, Extensa, SPRINT Peripheral Nerve Stimulation System, Endura, SPRINT Clinical Programmer Kit
K181422 is the FDA 510(k) clearance record for SPRINT Peripheral Nerve Stimulation System, Extensa, SPRINT Peripheral Nerve Stimulation System, Endura, SPRINT Clinical Programmer Kit, a class II device, cleared for Spr Therapeutics, Inc. on under FDA product code NHI (Stimulator, Nerve, Electrical, Percutaneous (Pens), For Pain Relief). FDA's definition for product code NHI reads: "Percutaneous electrical nerve stimulator (pens) is a device used for the treatment of pain. Unlike the classified transcutaneous electrical nerve stimulator that apply an electrical current to electrodes on a patient's skin to deliver...". FDA records list 7 510(k) clearances for Spr Therapeutics, Inc., from to . As of , FDA records show no recalls naming K181422.
Clearance record
- Decision date
- Received
- (61 days to decision)
- Product code
- NHI Stimulator, Nerve, Electrical, Percutaneous (Pens), For Pain Relief
- Regulation
- 21 CFR 882.5890
- Device class
- Class II
- Review panel
- Neurology
- Applicant
- Spr Therapeutics, Inc. 22901 Millcreek Blvd. Suite 110, Cleveland OH
- 510(k) summary
- Summary PDF
- Third party review
- No
Clearances, product code NHI
Trailing 12 monthsFDA records hold no clearances under product code NHI in the trailing twelve months.
Show the numbers
| Month | Clearances |
|---|---|
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 0 |
| March 2026 | 0 |
| April 2026 | 0 |
| May 2026 | 0 |
| June 2026 | 0 |
| July 2026 | 0 |
| August 2026 | 0 |
| September 2026 | 0 |
| October 2026 | 0 |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
